Other than clinical presentation, including severely elevated triglyceride levels, recurrent pancreatitis, and xanthomas, the diagnosis of FCS relies on genetic testing, lipoprotein lipase activity, and a recently validated FCS clinical scoring system. The gene discussed is LPL; the disease is xanthoma.